Journal of Inflammation Research · 2023 · 31 citations · 23 references
Veterinary MedicineEmergency MedicineClinical Classification SystemsClinical EpidemiologyInflammationAcute InflammationImmune-mediated Inflammatory DiseasesInflammatory BiomarkersInflammatory SignalingNeutrophil BiologySubarachnoid HemorrhageBiomarker-based Prognostic ModelsDiagnostic Inflammatory BiomarkersFunctional PrognosisIn-hospital MortalityNeutrophil-to-lymphocyte RatioPrognostic Inflammatory BiomarkersPropensity Score AdjustmentSubarachnoid Hemorrhage Prognostication
Purpose: Systemic inflammation plays an important role in the pathophysiology and progression of aneurysmal subarachnoid hemorrhage (aSAH). In this study, we aimed to investigate the association between a new biomarker, the inflammatory burden index (IBI) and the prognosis as well as in-hospital complications of aSAH patients. Patients and Methods: We analyzed data from patients with aSAH between January 2019 and September 2022 who were included in the LongTEAM (Long-term Prognosis of Emergency Aneurysmal Subarachnoid Hemorrhage) registry study. The IBI was formulated as C-reactive protein × neutrophils/lymphocytes. The unfavorable functional prognosis was assessed by the modified Rankin Scale (mRS). Receiver operating characteristic (ROC) curve analysis was conducted to determine the optimal cut-off values for IBI to distinguish the unfavorable functional prognosis. Multivariate logistic regression was applied to investigate the association between IBI and in-hospital complications. Propensity score matching was adjusted for imbalances in baseline characteristics to assess the effect of IBI on prognosis. Results: A total of 408 consecutive patients with aSAH enrolled in the study, of which 235 (57.6%) were female patients and the mean age was 55.28 years old. An IBI equal to 138.03 was identified as the best cut-off threshold to distinguish the unfavorable prognosis at 3 months (area under the curve [AUC] [95% CI] 0.637 [0.568-0.706]). ln IBI was independently associated with 3-month functional prognosis (OR [95% CI] 1.362 [1.148-1.615]; P<0.001), pneumonia (OR [95% CI] 1.427 [1.227-1.659]; P<0.001) and deep venous thrombosis (DVT). (OR [95% CI] 1.326 [1.124-1.564]; P=0.001). After propensity score matching (57:57), an increased proportion of patients with IBI ≥138.03 had a poor functional prognosis at 3 months and in-hospital complications including developed pneumonia and DVT. Conclusion: In patients with aSAH, high IBI level at admission was associated with unfavorable functional prognosis as well as pneumonia and deep vein thrombosis.
23
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
E. Sander Connolly, Alejandro A. Rabinstein, J. Ricardo Carhuapoma et al. · Stroke · 2012 · 3.5K citations · Full text
Increased Sympathetic Nervous Activity in Patients With Nontraumatic Subarachnoid Hemorrhage
Silvana Naredi, Gavin Lambert, Elisabeth Edén et al. · Stroke · 2000 · 358 citations
Inflammatory burden as a prognostic biomarker for cancer
Hailun Xie, Guo‐Tian Ruan, Yi‐Zhong Ge et al. · Clinical Nutrition · 2022 · 152 citations
Medicine, Immunology, Oncology +14
Immunodepression After Aneurysmal Subarachnoid Hemorrhage
Asita Sarrafzadeh, Florian Schlenk, Andreas Meisel et al. · Stroke · 2010 · 142 citations